Literature DB >> 9807974

Gut motility and transit changes in patients receiving long-term methadone maintenance.

C S Yuan1, J F Foss, M O'Connor, J Moss, M F Roizen.   

Abstract

This study was conducted to survey gut motility and transit in 19 volunteers receiving methadone maintenance who were opioid-dependent, and to measure the oral-cecal transit time in these individuals using the lactulose hydrogen breath test. None of these patients reported constipation problems before use of illicit drugs. During current long-term methadone therapy, 58% of patients experienced some degree of constipation, and two of these 19 patients reported that constipation was a very serious problem. Mean +/- standard deviation (SD) oral-cecal transit time in these individuals was 159+/-49.2 minutes, which is significantly longer than the transit time recorded in two previous studies of healthy volunteers (P < 0.01). These results indicate that tolerance to opioids does not appear to extend to gastrointestinal motility and transit. It seems that patients receiving long-term methadone therapy are a good model for use in evaluating gastrointestinal effects of opioid antagonists.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9807974     DOI: 10.1002/j.1552-4604.1998.tb04389.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  11 in total

1.  [Strong opioids and constipation].

Authors:  A Schwarzer; F Nauck; E Klaschik
Journal:  Schmerz       Date:  2005-06       Impact factor: 1.107

Review 2.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

Review 3.  Site and mechanism of morphine tolerance in the gastrointestinal tract.

Authors:  H I Akbarali; A Inkisar; W L Dewey
Journal:  Neurogastroenterol Motil       Date:  2014-10       Impact factor: 3.598

Review 4.  Opioid induced bowel disease: a twenty-first century physicians' dilemma. Considering pathophysiology and treatment strategies.

Authors:  Ankush Sharma; M Mazen Jamal
Journal:  Curr Gastroenterol Rep       Date:  2013-07

Review 5.  Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.

Authors:  R Brown; C Kraus; M Fleming; S Reddy
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

6.  The Guts of the Opioid Crisis.

Authors:  Karan H Muchhala; Joanna C Jacob; Minho Kang; William L Dewey; Hamid I Akbarali
Journal:  Physiology (Bethesda)       Date:  2021-09-01

7.  Morphine tolerance in the mouse ileum and colon.

Authors:  Gracious R Ross; Bichoy H Gabra; William L Dewey; Hamid I Akbarali
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

Review 8.  Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.

Authors:  Andrea Kurz; Daniel I Sessler
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Measurement of Gastrointestinal and Colonic Motor Functions in Humans and Animals.

Authors:  Michael Camilleri; David R Linden
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-07

Review 10.  Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals.

Authors:  Lynn R Webster; Michael Camilleri; Andrew Finn
Journal:  Subst Abuse Rehabil       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.